PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Dietary supplementation with calamondin puree in HFD-fed mice reduced lipid accumulation in the liver, decreased hepatocyte ballooning, and lowered serum inflammation-associated Ccl2 [PMID:32862731]
A calamansi drink was found to have a Glycaemic Index (GI) of 37, placing it within the range of low GI foods in healthy adult males [PMID:32859257]
Crude extract of C. microcarpa exhibited antitumor activity against HT29 human colon adenocarcinoma tumors in immunosuppressed mice [PMID:37505754]
Peel oils exhibited moderate antibacterial activity against E. coli (MIC 200 µg/mL) and showed synergism with tetracycline [PMID:37898554]
Evidence summary
PubMed sources
- 1.PMID: 35013363 (2022) — Evaluation on the phenotypic diversity of Calamansi (Citrus microcarpa) germplasm in Hainan island. · Scientific reports
- 2.PMID: 28911534 (2017) — Phenolic compounds and biological activities of small-size citrus: Kumquat and calamondin. · Journal of food and drug analysis
- 3.PMID: 37110643 (2023) — Phytochemicals, Bioactive Properties and Commercial Potential of Calamondin (Citrofortunella microcarpa) Fruits: A Review. · Molecules (Basel, Switzerland)
- 4.PMID: 23107680 (2012) — Characterisation of calamansi (Citrus microcarpa). Part II: volatiles, physicochemical properties and non-volatiles in the juice. · Food chemistry
- 5.PMID: 28930243 (2017)